nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP2D6—Captopril—systemic scleroderma	0.114	0.526	CbGbCtD
Alogliptin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0571	0.263	CbGbCtD
Alogliptin—Serum sickness—Captopril—systemic scleroderma	0.0515	0.0658	CcSEcCtD
Alogliptin—CYP3A4—Prednisone—systemic scleroderma	0.0457	0.211	CbGbCtD
Alogliptin—Pancreatitis acute—Prednisone—systemic scleroderma	0.022	0.0281	CcSEcCtD
Alogliptin—Diabetes mellitus—Captopril—systemic scleroderma	0.0202	0.0257	CcSEcCtD
Alogliptin—Nasopharyngitis—Mometasone—systemic scleroderma	0.0178	0.0228	CcSEcCtD
Alogliptin—Diabetes mellitus—Leflunomide—systemic scleroderma	0.0166	0.0212	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.016	0.0205	CcSEcCtD
Alogliptin—Diabetes mellitus—Mycophenolic acid—systemic scleroderma	0.0158	0.0202	CcSEcCtD
Alogliptin—Pancreatitis—Captopril—systemic scleroderma	0.0149	0.019	CcSEcCtD
Alogliptin—Diabetes mellitus—Lisinopril—systemic scleroderma	0.0143	0.0182	CcSEcCtD
Alogliptin—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.0141	0.018	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.0134	0.0171	CcSEcCtD
Alogliptin—Pancreatitis—Azathioprine—systemic scleroderma	0.013	0.0166	CcSEcCtD
Alogliptin—Angioedema—Pentoxifylline—systemic scleroderma	0.0127	0.0163	CcSEcCtD
Alogliptin—Hypoglycaemia—Lisinopril—systemic scleroderma	0.0127	0.0162	CcSEcCtD
Alogliptin—Diabetes mellitus—Mycophenolate mofetil—systemic scleroderma	0.0125	0.016	CcSEcCtD
Alogliptin—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.0123	0.0157	CcSEcCtD
Alogliptin—Pancreatitis—Leflunomide—systemic scleroderma	0.0122	0.0156	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.0117	0.0149	CcSEcCtD
Alogliptin—Pancreatitis—Mycophenolic acid—systemic scleroderma	0.0117	0.0149	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.0116	0.0148	CcSEcCtD
Alogliptin—Erythema multiforme—Captopril—systemic scleroderma	0.0115	0.0146	CcSEcCtD
Alogliptin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0114	0.0145	CcSEcCtD
Alogliptin—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0142	CcSEcCtD
Alogliptin—Nasopharyngitis—Lisinopril—systemic scleroderma	0.0111	0.0142	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.0111	0.0141	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.011	0.0141	CcSEcCtD
Alogliptin—Angioedema—Mometasone—systemic scleroderma	0.011	0.014	CcSEcCtD
Alogliptin—Pancreatitis—Lisinopril—systemic scleroderma	0.0105	0.0134	CcSEcCtD
Alogliptin—Erythema multiforme—Azathioprine—systemic scleroderma	0.01	0.0128	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00997	0.0127	CcSEcCtD
Alogliptin—Anaphylactic shock—Mometasone—systemic scleroderma	0.00981	0.0125	CcSEcCtD
Alogliptin—Angioedema—Captopril—systemic scleroderma	0.00965	0.0123	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00948	0.0121	CcSEcCtD
Alogliptin—Erythema multiforme—Leflunomide—systemic scleroderma	0.00945	0.0121	CcSEcCtD
Alogliptin—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00922	0.0118	CcSEcCtD
Alogliptin—Urticaria—Pentoxifylline—systemic scleroderma	0.00903	0.0115	CcSEcCtD
Alogliptin—Anaphylactic shock—Captopril—systemic scleroderma	0.00862	0.011	CcSEcCtD
Alogliptin—Diabetes mellitus—Prednisone—systemic scleroderma	0.00848	0.0108	CcSEcCtD
Alogliptin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00838	0.0107	CcSEcCtD
Alogliptin—Erythema multiforme—Lisinopril—systemic scleroderma	0.00812	0.0104	CcSEcCtD
Alogliptin—Angioedema—Leflunomide—systemic scleroderma	0.00795	0.0102	CcSEcCtD
Alogliptin—Rash—Pentoxifylline—systemic scleroderma	0.00717	0.00915	CcSEcCtD
Alogliptin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00716	0.00914	CcSEcCtD
Alogliptin—Headache—Pentoxifylline—systemic scleroderma	0.00712	0.00909	CcSEcCtD
Alogliptin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0071	0.00907	CcSEcCtD
Alogliptin—Diabetes mellitus—Methotrexate—systemic scleroderma	0.00708	0.00905	CcSEcCtD
Alogliptin—Angioedema—Lisinopril—systemic scleroderma	0.00683	0.00872	CcSEcCtD
Alogliptin—Pancreatitis—Prednisone—systemic scleroderma	0.00625	0.00798	CcSEcCtD
Alogliptin—Rash—Mometasone—systemic scleroderma	0.00618	0.0079	CcSEcCtD
Alogliptin—Dermatitis—Mometasone—systemic scleroderma	0.00618	0.00789	CcSEcCtD
Alogliptin—Headache—Mometasone—systemic scleroderma	0.00614	0.00785	CcSEcCtD
Alogliptin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.0061	0.00779	CcSEcCtD
Alogliptin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00598	0.00764	CcSEcCtD
Alogliptin—Urticaria—Leflunomide—systemic scleroderma	0.00564	0.0072	CcSEcCtD
Alogliptin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00554	0.00707	CcSEcCtD
Alogliptin—Rash—Captopril—systemic scleroderma	0.00543	0.00694	CcSEcCtD
Alogliptin—Dermatitis—Captopril—systemic scleroderma	0.00543	0.00693	CcSEcCtD
Alogliptin—Headache—Captopril—systemic scleroderma	0.0054	0.00689	CcSEcCtD
Alogliptin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00535	0.00683	CcSEcCtD
Alogliptin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00523	0.00668	CcSEcCtD
Alogliptin—Pancreatitis—Methotrexate—systemic scleroderma	0.00522	0.00667	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00495	0.00632	CcSEcCtD
Alogliptin—Urticaria—Lisinopril—systemic scleroderma	0.00485	0.00619	CcSEcCtD
Alogliptin—Rash—Azathioprine—systemic scleroderma	0.00474	0.00605	CcSEcCtD
Alogliptin—Dermatitis—Azathioprine—systemic scleroderma	0.00474	0.00605	CcSEcCtD
Alogliptin—Headache—Azathioprine—systemic scleroderma	0.00471	0.00601	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00471	0.00601	CcSEcCtD
Alogliptin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00449	0.00574	CcSEcCtD
Alogliptin—Rash—Leflunomide—systemic scleroderma	0.00448	0.00572	CcSEcCtD
Alogliptin—Dermatitis—Leflunomide—systemic scleroderma	0.00447	0.00571	CcSEcCtD
Alogliptin—Headache—Leflunomide—systemic scleroderma	0.00445	0.00568	CcSEcCtD
Alogliptin—Rash—Mycophenolic acid—systemic scleroderma	0.00427	0.00545	CcSEcCtD
Alogliptin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00427	0.00545	CcSEcCtD
Alogliptin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00425	0.00542	CcSEcCtD
Alogliptin—Headache—Mycophenolic acid—systemic scleroderma	0.00424	0.00542	CcSEcCtD
Alogliptin—Angioedema—Prednisone—systemic scleroderma	0.00406	0.00518	CcSEcCtD
Alogliptin—Erythema multiforme—Methotrexate—systemic scleroderma	0.00403	0.00515	CcSEcCtD
Alogliptin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00394	0.00503	CcSEcCtD
Alogliptin—Rash—Lisinopril—systemic scleroderma	0.00385	0.00491	CcSEcCtD
Alogliptin—Dermatitis—Lisinopril—systemic scleroderma	0.00384	0.00491	CcSEcCtD
Alogliptin—Headache—Lisinopril—systemic scleroderma	0.00382	0.00488	CcSEcCtD
Alogliptin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00362	0.00463	CcSEcCtD
Alogliptin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00337	0.0043	CcSEcCtD
Alogliptin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00337	0.0043	CcSEcCtD
Alogliptin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00335	0.00428	CcSEcCtD
Alogliptin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00303	0.00387	CcSEcCtD
Alogliptin—Urticaria—Prednisone—systemic scleroderma	0.00288	0.00368	CcSEcCtD
Alogliptin—Hypersensitivity—Prednisone—systemic scleroderma	0.00267	0.00341	CcSEcCtD
Alogliptin—Urticaria—Methotrexate—systemic scleroderma	0.00241	0.00307	CcSEcCtD
Alogliptin—Rash—Prednisone—systemic scleroderma	0.00228	0.00292	CcSEcCtD
Alogliptin—Dermatitis—Prednisone—systemic scleroderma	0.00228	0.00291	CcSEcCtD
Alogliptin—Headache—Prednisone—systemic scleroderma	0.00227	0.0029	CcSEcCtD
Alogliptin—Hypersensitivity—Methotrexate—systemic scleroderma	0.00223	0.00285	CcSEcCtD
Alogliptin—Rash—Methotrexate—systemic scleroderma	0.00191	0.00244	CcSEcCtD
Alogliptin—Dermatitis—Methotrexate—systemic scleroderma	0.00191	0.00244	CcSEcCtD
Alogliptin—Headache—Methotrexate—systemic scleroderma	0.0019	0.00242	CcSEcCtD
